开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2022-05-16 wqstnyy

审稿速度:1.0
偏重的研究方向：传染病;细菌;糖尿病
经验分享：经验有一点点

94 0

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2022-02-28 ms7000000140422300

请问版面费多少呢？官网上没有看到

93 0

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

什么是comment？

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

什么是letter?

105 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2021-09-07 ms4000001881910101

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：病原逃避
经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。

119 0

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2021-06-29 侧面2002

审稿速度:3.0
经验分享：挺不错的杂志

111 0

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2020-05-03 ILVhera

审稿8-12周，可以催，二审比一审快点，也要两三周

188 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2020-02-23 huxiaoyan

接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表:
求问接受么

wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么

163 0

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2019-10-31 ILVhera

好慢一审48天还没回来催稿了

185 0

[GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0 偏重的研究方向：传染病;细菌;糖尿病 经验分享：经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢？官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：病原逃避 经验分享：2月提交，4月返修。三个评审中一个比较苛刻要求文字和讨论加强，一个赞许，一个给了提了意见修改。补了实验后，6月二次提交，两周内回复，两个评审满意，第一个认为还是没有针对他的意见进行修改。二次提交了修改版本，7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0 经验分享：挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周，可以催，二审比一审快点，也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗？wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢一审48天还没回来催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]

2019-09-16 ILVhera

现在在么样，楼主kikishaw 2019-07-17 00:00:00 发表:
2个月初审没消息，发了邮件询问也不回复，急的就别投了

kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息，发了邮件询问也不回复，急的就别投了

200 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务